The global Birth Control Patch market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The birth control patch is a contraceptive device that contains the hormones estrogen and progestin.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
LP Information, Inc. (LPI) ' newest research report, the “Birth Control Patch Industry Forecast” looks at past sales and reviews total world Birth Control Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Birth Control Patch sales for 2025 through 2031. With Birth Control Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Birth Control Patch industry.
This Insight Report provides a comprehensive analysis of the global Birth Control Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Birth Control Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Birth Control Patch market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Birth Control Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Birth Control Patch.
This report presents a comprehensive overview, market shares, and growth opportunities of Birth Control Patch market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Seven Days Replacement
Three Days Replacement
Segmentation by Application:
Online Sales
Offline Sales
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Viatris
Agile Therapeutics
Ortho-McNeil Pharmaceuticals
Mylan
Lvye Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Birth Control Patch market?
What factors are driving Birth Control Patch market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Birth Control Patch market opportunities vary by end market size?
How does Birth Control Patch break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook